Engagement of the natural cytotoxicity receptors NKp30, NKp44, and/or NKp46 from CD56bright NK cells is required to suppress autologous T cells from untreated patients with RRMS in vitro (23). Here, NCR1 is linked to relapsing-remitting multiple sclerosis.